Patient's Immunochemistry at Presentation and Posttreatment, 2016-2017
| Laboratory Test Date | ||||||||
|---|---|---|---|---|---|---|---|---|
| Test | Reference Range | Presentation and Admission | Discharge | Posttreatment | ||||
| 11/17/16 | 11/22/16 | 11/22/16 | 11/24/16 | 12/6/16 | 1/25/17 | 3/21/17 | ||
| Double-stranded DNA antibody (dsDNA) | Negative 1:10 | Positive 1:2560 | Positive 1:2560 | Positive 1:20 | Negative 1:10 | |||
| Anti-Smith antibody, relative units | 0.00-19.99 | 5.04 | ||||||
| Antihistone antibody, units | 0.0-0.9 | 3.5 | ||||||
| Cytoplasmic neutrophilic antibody | <1:20 titer | <1:20 | ||||||
| Perinuclear antineutrophil cytoplasmic antibody (P-ANCA) | <1:20 titer | <1:20 | ||||||
| Proteinase 3 antineutrophil cytoplasmic antibody (PR3-ANCA) | Negative <0.4 | <0.2 | ||||||
| Complement 3 (C3), mg/dL | 50-180 | 71 | 65 | 53 | 120 | 144 | ||
| Complement 4 (C4), mg/dL | 11-44 | 13 | 13 | 11 | 34 | 40 | ||
| Anti-glomerular basement membrane antibody, units | <1.0 | <0.2 | <0.2 | |||||
| Computed tomography urology | Negative | |||||||